未登录

H

Hui-Ju Hsieh

ut md anderson cancer center

H指数:8

被引数:375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma

Capivasertib 增强了 B 细胞淋巴瘤的 preclinical models 中嵌合抗原受体 T 细胞的活性。

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT

IF4.7

2025-03-010

OAAI

Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression

MOLECULAR THERAPY

IF12

2024-02-013

OAAI

Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery

NATURE COMMUNICATIONS

IF15.7

2018-09-2831

OAAI

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells

IF6.4

2017-04-1750

OAAI

Cellular responses to replication stress: Implications in cancer biology and therapy

细胞对复制应激的反应: 在癌症生物学和治疗中的意义

IF2.7

2017-01-0111

PREAI

Phosphorylation of the BRCA1C Terminus (BRCT) Repeat Inhibitor of hTERT (BRIT1) Protein Coordinates TopBP1 Protein Recruitment and Amplifies Ataxia Telangiectasia-mutated and Rad3-related (ATR) Signaling

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2014-12-018

OAAI

Human Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection

CANCER RESEARCH

IF16.6

2012-05-3176

OA

Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2012-02-0193

OAAI